Drugmaker Baxter HealthCare Corp., which makes half of the blood thinner Heparin sold in the United States, is temporarily suspending production of some injectable doses of the med after reports of severe allergic reactions--and possibly four deaths--in some patients. Heparin is used to prevent blood clots in patients undergoing such procedures as kidney dialysis and heart surgery. Baxter's announcement means that there could be a shortage of the medication, and health officials are working...
Read moreYou often hear nutrition experts extol the virtues of fruits and vegetables because of their nutrient content. Eating a variety of... Read more »
Reports about contaminated supplies of the blood thinner heparin raise a number of big, unsettling questions about the global economy, the... Read more »
Full Question: Oxygen and Heparin Administered via a Nebulizer for Migraine Mitigation? Are you aware of any research or protocol... Read more »
Key to making the most of therapeutic activities is engagement and good communication skills. Where the activity takes place matters less... Read more »
One of the things that I’ve embraced is the power of the massage. It’s amazing how this procedure can make you feel sooooo much better... Read more »
Officials with the U.S. Food and Drug Administration say they've identified the contaminant found in doses of the blood-thinning drug heparin that... Read more »
Two patients in Delaware have died after receiving the drug heparin, a widely used blood thinner made by Baxter International Inc. The two deaths... Read more »
The commonly used blood thinner Heparin may cause skin lesions that are themselves harmless in most cases. But experts say the lesions could be a... Read more »
Stroke patients who suffer from paralysis are helped more by Lovenox than heparin, a new study suggests. Researchers gave 1,762 stroke patients who... Read more »
Low-dose treatment with acetretin, a drug used to treat skin psoriasis, seems to help reduce nail psoriasis, according to Italian researchers. Read more »